ZimVie ennounces expanded reimbursement for Mobi-C in France

ZimVie announced that the French Republic has published its approval for the reimbursement of the Mobi-C Cervical Disc in both the public and private sectors in France. In addition, the clinical data for Mobi-C was awarded the highest quality rating of 10A by the Orthopaedic Data Evaluation Panel in the United Kingdom. Physicians have used Mobi-C, ZimVie’s market-leading device for cervical disc replacement at one level or two contiguous levels, to treat patients in France and the U.K. since 2004. On March 19, 2023, the French Republic’s Ministry of Health and Prevention issued in JORF N degrees 0067, a new version of the List of Products and Services reimbursable by health insurance and covered by the Health Insurance Fund. The LPP now includes the newly introduced medical device code 3174999 for "Cervical Disc Prostheses – Mobi-C Plug & Fit." Implants included on the LPP must be CE-marked devices that have a therapeutic, diagnostic, or assistive added value, supported by clinical studies demonstrating the benefits of the solution. Another validation of the Mobi-C Cervical Disc came through the recent 10A rating from the Orthopaedic Data Evaluation Panel in the United Kingdom. ODEP provides the objective, systematic review and rating of the strength of evidence supporting the performance of medical devices. Its rating is comprised of several components: The numerical portion of the rating indicates the number of years of clinical evidence, with ten years representing full compliance with the benchmark from the National Institute for Health and Care Excellence, which provides national guidance and advice to improve health and social care in the United Kingdom. The "A" designates "Strong Evidence" based on a generally higher number of patients, with all patients being subject to follow-up. Finally, the addition of the star denotes a benchmark replacement rate of less than 1 in 20 at 10 years. There is no higher quality rating than A.